BBLGWBone Biologics Corpvs its industry peers
A metric-by-metric comparison of Bone Biologics Corp against SIC 3842 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBLGWThis | $25M#7 | — | 6.2x#8 | 0.0x#3 | 0.0%#7 | 24.4%#1 | -0.3%#2 | -79.2%#6 | — | — | — | — |
| LAKE | $104M#1 | — | 0.8x#5 | 0.5x#4 | 15.2%#2 | -40.0%#12 | -8.1%#4 | -20.2%#3 | -15.4%#1 | 3#2 | -27.2%#4 | 1.1%#3 |
| SPAI | $89M#2 | — | 7.4x#9 | 146.3x#12 | -72.0%#14 | -92.8%#13 | -2397.6%#10 | -119.6%#8 | -771.1%#6 | 4#1 | -41.2%#5 | — |
| NTRB | $84M#3 | — | 15.8x#11 | 41.3x#10 | -4.8%#12 | 21.5%#3 | -408.4%#7 | -154.4%#9 | -212.9%#4 | — | -3.4%#3 | — |
| COCH | $56M#4 | — | 17.1x#12 | 233.8x#13 | 7.1%#3 | -14.2%#10 | -9240.7%#11 | -719.2%#11 | — | — | -42.5%#6 | 3.2%#2 |
| APT | $53M#5 | 13.4x#1 | 0.8x#4 | 0.9x#5 | 2.3%#6 | -10.3%#9 | 6.5%#1 | 5.4%#2 | — | — | 7.5%#2 | — |
| MLSS | $36M#6 | — | 10.4x#10 | 4.0x#7 | 4.0%#5 | 21.4%#5 | -63.5%#5 | 164.9%#1 | — | — | — | — |
| HSCS | $16M#8 | — | — | 3723.2x#14 | -0.7%#10 | -4.3%#7 | -194787.4%#13 | — | — | — | — | — |
| NTRBW | $12M#9 | — | 2.2x#7 | 5.7x#8 | -4.8%#12 | 21.5%#3 | -408.4%#7 | -154.4%#9 | -212.9%#4 | — | — | — |
| FEED | $10M#10 | — | 0.3x#2 | 3.8x#6 | -0.2%#9 | -390.8%#14 | -896.6%#9 | -59.1%#5 | -74.0%#2 | — | — | — |
| COCHW | $4M#11 | — | 1.2x#6 | 16.6x#9 | 7.1%#3 | -14.2%#10 | -9240.7%#11 | -719.2%#11 | — | — | — | 45.4%#1 |
| BBLG | $1M#12 | — | 0.4x#3 | 0.0x#2 | 0.0%#7 | 24.4%#1 | -0.3%#2 | -79.2%#6 | — | — | — | — |
| HSCSW | $334092#13 | — | — | 77.4x#11 | -0.7%#10 | -4.3%#7 | -194787.4%#13 | — | — | — | 12.8%#1 | — |
| LGMK | $10077#14 | — | 0.0x#1 | 0.0x#1 | 15.4%#1 | 17.1%#6 | -69.1%#6 | -56.6%#4 | -76.3%#3 | 3#2 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3842). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice